Molecule Holdings(TSE:MLCL)
CA$0.010.00 (0.00%)
TSE:MLCL
Molecule Holdings financials statements
CA$0.01
At close:0.00 (0.00%)
Molecule Holdings (MLCL) Ratios
6 Followers
Molecule Holdings Ratios
TSE:MLCL's free cash flow for Q3 2023 was C$-7.62K. For the 2023 fiscal year, TSE:MLCL's free cash flow was increased by C$1.00 and operating cash flow was C$-7.62K. See a summary of the company’s cash flow.
| Ratios | Jan 23 | Oct 21 | Jan 21 | Oct 19 |
|---|---|---|---|---|
| Liquidity Ratios | ||||
| Current Ratio | 0.17 | 0.62 | 1.34 | 4.83 |
| Quick Ratio | 0.09 | 0.47 | 1.21 | 4.83 |
| Cash Ratio | 0.01 | 0.28 | 0.79 | 4.13 |
| Solvency Ratio | -0.59 | -0.81 | -0.96 | -1.47 |
| Operating Cash Flow Ratio | -0.15 | -0.66 | -0.81 | -1.64 |
| Short-Term Operating Cash Flow Coverage | -0.22 | -0.82 | 0.00 | 0.00 |
| Net Current Asset Value | C$ -6.32M | C$ -2.61M | C$ -483.83K | C$ 1.94M |
| Leverage Ratios | ||||
| Debt-to-Assets Ratio | 1.33 | 0.75 | 0.16 | 0.04 |
| Debt-to-Equity Ratio | -1.41 | 6.96 | 0.25 | 0.05 |
| Debt-to-Capital Ratio | 3.46 | 0.87 | 0.20 | 0.05 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.56 | 0.17 | 0.00 |
| Financial Leverage Ratio | -1.06 | 9.33 | 1.59 | 1.17 |
| Debt Service Coverage Ratio | -0.67 | -0.88 | -42.25 | -68.54 |
| Interest Coverage Ratio | -6.17 | -5.13 | -72.14 | -69.34 |
| Debt to Market Cap | 1.17 | 0.94 | 0.11 | 0.00 |
| Interest Debt Per Share | 0.06 | 0.06 | 0.01 | 0.05 |
| Net Debt to EBITDA | -1.32 | -1.08 | 0.01 | 1.98 |
| Profitability Margins | ||||
| Gross Profit Margin | -54.56% | -109.77% | 0.00% | 0.00% |
| EBIT Margin | -198.59% | -783.46% | 0.00% | 0.00% |
| EBITDA Margin | -196.57% | -658.90% | 0.00% | 0.00% |
| Operating Profit Margin | -198.86% | -744.65% | 0.00% | 0.00% |
| Pretax Profit Margin | -230.84% | -928.56% | 0.00% | 0.00% |
| Net Profit Margin | -230.84% | -1074.42% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | -230.84% | -928.56% | 0.00% | 0.00% |
| Net Income Per EBT | 100.00% | 115.71% | 59.41% | 101.42% |
| EBT Per EBIT | 116.08% | 124.70% | 103.42% | 101.44% |
| Return on Assets (ROA) | -116.15% | -82.13% | -36.29% | -21.91% |
| Return on Equity (ROE) | 122.98% | -766.21% | -57.52% | -25.63% |
| Return on Capital Employed (ROCE) | 108.50% | -211.77% | -74.65% | -23.92% |
| Return on Invested Capital (ROIC) | -250.72% | -65.97% | -43.91% | -23.73% |
| Return on Tangible Assets | -116.15% | -82.13% | -36.29% | -21.91% |
| Earnings Yield | -103.98% | -106.50% | -30.71% | -297.11% |
| Efficiency Ratios | ||||
| Receivables Turnover | 6.95 | 1.16 | 0.00 | 0.00 |
| Payables Turnover | 1.77 | 1.29 | 0.05 | 0.05 |
| Inventory Turnover | 5.01 | 1.49 | 0.33 | 0.00 |
| Fixed Asset Turnover | 0.75 | 0.14 | 0.00 | 0.00 |
| Asset Turnover | 0.50 | 0.08 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | -0.50 | -0.72 | 0.00 | 0.00 |
| Cash Conversion Cycle | -81.23 | 274.78 | -6160.79 | -6676.96 |
| Days of Sales Outstanding | 52.51 | 313.63 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 72.89 | 244.74 | 1105.83 | 0.00 |
| Days of Payables Outstanding | 206.63 | 283.60 | 7266.62 | 6676.96 |
| Operating Cycle | 125.40 | 558.38 | 1105.83 | 0.00 |
| Cash Flow Ratios | ||||
| Operating Cash Flow Per Share | -0.01 | -0.03 | -0.01 | -0.20 |
| Free Cash Flow Per Share | -0.01 | -0.03 | -0.04 | -0.60 |
| Dividend Paid and CapEx Coverage Ratio | -34.11 | -37.33 | -0.49 | -0.48 |
| Capital Expenditure Coverage Ratio | -34.11 | -37.33 | -0.49 | -0.48 |
| Operating Cash Flow Coverage Ratio | -0.22 | -0.65 | -1.06 | -4.22 |
| Operating Cash Flow to Sales Ratio | -0.57 | -6.30 | 0.00 | 0.00 |
| Free Cash Flow Yield | -26.60% | -64.14% | -43.89% | -752.22% |
| Valuation Ratios | ||||
| Price-to-Earnings (P/E) Ratio | -0.96 | -0.94 | -3.26 | -0.34 |
| Price-to-Sales (P/S) Ratio | 2.22 | 10.09 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | -1.18 | 7.19 | 1.87 | 0.09 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -3.76 | -1.56 | -2.28 | -0.13 |
| Price-to-Operating Cash Flow Ratio | -3.87 | -1.60 | -6.95 | -0.41 |
| Price-to-Earnings Growth (PEG) Ratio | 0.08 | -0.01 | 0.04 | 0.00 |
| Enterprise Value Multiple | -2.45 | -2.61 | -1.98 | 1.62 |
| Enterprise Value | 9.48M | 7.83M | 6.41M | -1.70M |
| EV to EBITDA | -2.45 | -2.61 | -1.98 | 1.62 |
| EV to Sales | 4.82 | 17.20 | 0.00 | 0.00 |
| EV to Free Cash Flow | -8.16 | -2.66 | -2.27 | 0.61 |
| EV to Operating Cash Flow | -8.40 | -2.73 | -6.92 | 1.87 |
| Tangible Book Value Per Share | -0.04 | 0.01 | 0.05 | 0.93 |
| Shareholders’ Equity Per Share | -0.04 | 0.01 | 0.05 | 0.93 |
| Tax and Other Ratios | ||||
| Effective Tax Rate | 0.00 | -0.16 | 0.41 | -0.01 |
| Revenue Per Share | 0.02 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.05 | -0.05 | -0.03 | -0.24 |
| Tax Burden | 1.00 | 1.16 | 0.59 | 1.01 |
| Interest Burden | 1.16 | 1.19 | 1.01 | 1.01 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 1.31 | 5.33 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.04 | 2.32 | 0.00 | 0.00 |
| Income Quality | 0.25 | 0.68 | 0.28 | 0.83 |
Currency in CAD

